2'-fucosyllactose for use in stimulating f. prausnitzii abundance
AssigneeFrieslandCampina Nederland B.V.
InventorArjen Nauta
Life of this patent
Estimating the term…
Abstract
Preparation of dietary fibers for increasing the abundance of Faecalibacteriumprausnitzii in the gastrointestinal tract of a human subject, the dietary fibers in said preparation consisting essentially of 2′-fucosyllactose (2′-FL) and optionally one or more further oligosaccharides selected from the group consisting of galacto-oligosaccharides, fructo-oligosaccharides, resistant starch, polydextrose, and human milk oligosaccharides other than 2′-fucosyllactose.
Claims20
A method of increasing the abundance of Faecalibacterium prausnitzii in the gastrointestinal tract of a human subject, the method comprising administering to the human subject an effective amount of a preparation of dietary fibers, the dietary fibers in said preparation consisting essentially of 2′-fucosyllactose (2′-FL) and optionally one or more further oligosaccharides selected from the group consisting of galacto-oligosaccharides, fructo-oligosaccharides, resistant starch, polydextrose, and human milk oligosaccharides other than 2′-fucosyllactose.
A method of increasing the abundance of Faecalibacterium prausnitzii in the gastrointestinal tract of a human subject suffering from or being at risk of developing COVID-19 or a SARS-CoV-2 infection, an inflammatory bowel condition, diabetes, anxiety, and/or allergies, the method comprising administering to the human subject an effective amount of a preparation of dietary fibers consisting essentially of 2′-fucosyllactose (2′-FL) and optionally one or more further oligosaccharides selected from the group consisting of galacto-oligosaccharides, fructo-oligosaccharides, resistant starch, and human milk oligosaccharides other than 2′-fucosyllactose.
Dependencies are inferred from the claim text.